P resympathetic neurons within the rostral ventrolateral medulla (RVLM) contain catecholamines and/or preproenkephalin (PPE) and are critical for the tonic and reflex control of arterial pressure (AP). [1] [2] [3] Inputs regulating RVLM presympathetic neuronal activity release amino acids and/or a range of modulatory neurochemicals, including peptides. [2] [3] [4] [5] [6] These underlie the ability to provide a differentiated sympathetic drive to the various vascular beds, 6 alter the responses to reflex activation, 5 and set the level of AP. 1, 3, 5 Identification of neurons responsible for generating and maintaining sympathetic vasomotor tone and, therefore, setting the level of AP would be a major breakthrough in understanding circulatory control.
The inhibitory neuropeptide somatostatin (SST) is distributed widely in regions of the central nervous system involved in motor, cognitive, autonomic, and neuroendocrine processes. 7, 8 Two biologically active forms of SST, SST 14 and SST 28, are cleaved from preprosomatostatin and bind to all of the SST receptors with similar affinity. 8 Six G protein-coupled SST receptors (sstRs) have been identified (sst1 through 5), including 2 splice variants, sst2A and sst2B. 7, 8 All of the sstRs are negatively coupled to adenylate cyclase, activate phosphotyrosine phosphatases, and modulate mitogen-activated protein (MAP) kinases, whereas subtype-specific actions are also evident. 7, 8 sstR and SST-containing cell bodies and terminals are present in the ventral medulla. 9 -11 Little is known about their functional roles, except that microinjection of SST evokes apnea. 12, 13 Furthermore, quantitative analysis of sstRcontaining neurons and their colocalization with other functional neuronal markers in the ventral medulla is lacking.
Our aims were, first, to comprehensively describe the cellular distribution of SST receptors in the sympathoexcitatory region of the RVLM, and, second, to determine the cardiovascular responses elicited by SST and sstR ligands microinjected into the RVLM. Finally, we sought to deter-mine whether SST receptors modulate the effectiveness of excitatory or inhibitory inputs into the RVLM.
Materials and Methods
An expanded Materials and Methods section is provided (please see http://hyper.ahajournals.org). Experiments were carried out on male Sprague-Dawley rats (nϭ47) with the approval of the animal care and ethics committees of Royal North Shore Hospital/University of Technology Sydney and Macquarie University, in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes.
Immunohistochemical and In Situ Hybridization Experiments
Cholera toxin B subunit (CTB; 1%, 200 nL, List Biological Laboratories) was bilaterally microinjected into the T1 spinal cord in sodium pentobarbitone (60 mg/kg, IP) anesthetized rats (nϭ10). After 24 hours of recovery, rats were reanesthetized, transcardially perfused, and brain stem and spinal cord sections were processed for light or fluorescence immunohistochemistry or combined in situ hybridization and immunohistochemistry, as described previously. 6, 14 mRNA for PPE, glutamic acid decarboxylase (GAD67), vesicular glutamate transporter 2 (VGluT2), or preprosomatostatin was revealed by in situ hybridization using digoxigenin-labeled antisense riboprobes. After hybridization, or for immunohistochemistry alone, sections were incubated with species-specific primary antibodies for digoxigenin (DAKO), tyrosine hydroxylase (TH, Sigma-Aldrich), SST receptors (Gramsch Laboratories), CTB, and/or synaptophysin (Synaptic Systems GmbH) and then washed and incubated with fluorophore/peroxidase-conjugated secondary antisera. 6 The RVLM was defined as the area ventral to the nucleus ambiguus, medial to the spinal trigeminal tract, and lateral to the inferior olive. Labeled RVLM neurons were counted from 4 hemisections, each separated by 200 m (nϭ4).
Electrophysiological Experiments
Electrophysiological experiments were conducted as described previously. 4, 6, 15 Urethane anesthetized (10% wt/vol in saline, 1.3 g/kg, IP, Sigma-Aldrich), vagotomized, paralyzed (pancuronium bromide, 0.4 mg/h, IV, Astra Pharmaceuticals), and artificially ventilated (end-tidal CO 2 4% to 5%) rats with body temperature maintained at 36.5Ϯ0.5°C (heating blanket, Harvard Apparatus) were used.
A tracheotomy was performed, and the jugular vein and carotid artery were cannulated to permit drug administration and record AP. Heart rate (HR) was derived from AP. The left greater splanchnic preganglionic and phrenic nerves were isolated and recorded using bipolar silver hook electrodes. All of the signals were acquired online using Spike2 software (CED Ltd). Animals were placed in a stereotaxic frame, and the dorsal medullary surface was exposed.
Unilateral or bilateral RVLM microinjections of drugs (Sigma-Aldrich unless otherwise stated) were made as described previously. 4 ,6,16 L-Glutamic acid (100 mmol/L), SST (SST-14, 15 mol/L, 150 mol/L, 450 mol/L, and 1.5 mmol/L, Auspep), muscimol (10 mmol/L), and colloidal gold (25% v/v) were dissolved in 10 mmol/L of PBS (pH 7.4), and 50 nL were administered. The sst2 receptor antagonist BIM-23627 (500 mol/L, Bachem) was dissolved in PBS (100 nL per microinjection), and the sst2 agonist, lanreotide (450 mol/L and 1.5 mmol/L, Bachem), was dissolved in 5% dimethyl sulfoxide/PBS. PBS was microinjected as vehicle control. We have demonstrated previously the small transient pressor effects evoked by 5% dimethyl sulfoxide/PBS in the RVLM. 17 Cardiovascular reflexes were evoked as described previously, 4,6,15 with intermittent stimulation of the barosensory aortic depressor nerve (ADN; 50 pulse train at 100 Hz; 0.2-ms pulse width; 3 to 5 times threshold; nϭ10), somatic sciatic nerve (single 0.2-ms pulse; 50 sweeps at 0.5 Hz; 2 times threshold; nϭ7), and carotid chemoreceptor activation by ventilating with nitrogen for 12 seconds (isocapnic anoxia; nϭ10). After experimentation, injection sites were marked, and rats were euthanized with KCl (3 mol/L, 0.5 mL, IV). Brainstems were removed, fixed, and sectioned to verify injection sites. 6 Data were analyzed as described previously. 4 
Results

SST Receptors in the RVLM
The distribution of sst1, 2A, 2B, 3, and 4 receptors in the RVLM was examined (please see Figure S1 ). Intense sst2A immunoreactivity (ir) was evident on somata, dendrites, and fibers throughout ( Figure S1B1 and S1B2). No labeling for sst1 or sst2B was observed ( Figure S1A1 and S1C1), although robust labeling was evident at other sites, including the nucleus ambiguus, dorsal and lateral horns of the thoracic spinal cord (sst1; Figure S1A2 ), and dorsal and lateral horn (sst2B; Figure S1C2 ). sst3-ir was detected within the RVLMlabeling neuronal cilia, as described in other brain sites 18 ( Figure S1D1 and S1D2). sst4-ir weakly labeled some somata, dendrites, and fibers in the RVLM ( Figure S1E1 and S1E2) but was abundantly expressed within the nucleus ambiguus ( Figure S1E1 ). Quantitative analysis was restricted to sst2A-ir.
RVLM neurons were examined for immunoreactivity for sst2A receptor, TH, CTB, and mRNA for PPE, GAD67, VGluT2, or preprosomatostatin. In the area containing TH-ir ( Figure 1A1 ) and bulbospinal neurons (CTB-ir; Figure 1A2 ), sst2A receptor-ir perikarya and fibers ( Figure 1A3 ) were concentrated. In the RVLM, most GAD67 neurons surrounded the most dense sst2A-ir ( Figure 1A3 through 1A4 ). Bulbospinal neurons (TH and non-TH containing) in the RVLM expressed the sst2A receptor ( Figure 1B1 through 1B4). A total of 56Ϯ5% (403 of 749 cells; , nϭ6) of bulbospinal neurons were TH-ir, of which 54Ϯ4% (216 of 403) were also sst2A-ir. A total of 35Ϯ5% (241 of 749) of bulbospinal neurons expressed sst2A, most of which contained TH (89Ϯ2%; 216 of 241). Almost all of the TH-ir/ CTB-ir/sst2A-ir neurons in the RVLM contained VGluT2 mRNA ( Figure 1C1 through 1C4) . A total of 24Ϯ3% of bulbospinal TH-ir neurons also contained PPE mRNA, which made up 64Ϯ9% of bulbospinal PPE neurons. sst2A was expressed by 30Ϯ3% (24 of 79; nϭ3) of bulbospinal PPE neurons ( Figure 1D1 through 1D4) and 34Ϯ3% of bulbospinal TH-ir/PPE mRNA-positive neurons.
No colocalization of sst2A-ir and GAD67 mRNA was observed ( Figure 1B1 through 1B4) . PPS mRNA was found in very few (4Ϯ1%) bulbospinal RVLM neurons (data not shown), as described previously. 10, 19 Although sst2A-ir neurons were closely apposed by synaptophysin-ir terminals, sst2A-ir did not seem to colocalize with synaptophysin-ir terminals ( Figure 1E1 through 1E4) , suggesting that inputs to RVLM do not express sst2A.
RVLM Injection of SST or Lanreotide Evokes Profound Sympathoinhibition and Hypotension
SST injected bilaterally at RVLM pressor sites evoked bradycardia, a large depressor response, and robust sympa-thoinhibition that approached levels seen after cervical spinal cord transection or death, together with small and transient effects on PNA ( Figure 2A ). Grouped data (nϭ8) are shown in Figure 2B . Figure 2C shows the responses evoked by bilateral SST followed 80 minutes later by injections of the preferentially selective sst2 receptor agonist lanreotide. Apart from the longer duration of response evoked by lanreotide (Ͼ2 hours) and smaller effects on HR, the profound sympathoinhibitory and depressor effects were identical (nϭ6; Figure 2B ). Dose-dependent responses were evoked with both drugs ( Figure 2D ) with SST (75 pmol per side) and lanreotide (75 pmol per side), eliciting similar levels of hypotension (Ϫ58Ϯ6 mm Hg, nϭ8; Ϫ59Ϯ5 mm Hg, nϭ6) and sympathoinhibition (Ϫ66Ϯ4%, nϭ8; Ϫ73Ϯ3% baseline, nϭ6) that were quantitatively similar to those seen after C1 spinal cord transection ( Figure 2D ). Figure 2D also shows the effects of unilateral SST.
Sympathoinhibitory Effects of SST in the RVLM Are Abolished by a Selective sst2A Receptor Antagonist
Similar magnitudes and duration of depressor and sympathoinhibitory responses were evoked by bilateral injections of SST followed Ͼ1 hour later by either injections of SST or of lanreotide, indicating that, with adequate intervals, tachyphylaxis did not occur ( Figures 2C, 3A , and 3B). Bilateral injection of the selective sst2A antagonist BIM-23627 (nϭ7) at RVLM sites at which SST or lanreotide had previously evoked strong sympathoinhibition abolished the effects of subsequent SST or lanreotide microinjection ( Figure 3C and 3D). Bilateral injection of BIM-23627 alone evoked small transient pressor effects similar to those evoked with PBS injection.
Effects of SST in the RVLM on PNA
Bilateral microinjection of SST at RVLM pressor sites occasionally caused transient apneas and small reductions in PNA amplitude (Figure 2A ). The respiratory effects of SST injection were mapped: prolonged apnea was often evoked by SST microinjection at caudal RVLM sites (12 mm caudal to bregma). More rostral (11.5 mm caudal to bregma) and medial injections evoked small transient if any effects on PNA ( Figure S2A and S2B). At more caudal ventrolateral medulla sites, 75 pmol per side SST evoked inhibition of PNA with little to no effect on SNA ( Figure S2B ) or MAP, as described previously. 12, 13 
Effects of SST in the RVLM on Reflex Function
Somatosympathetic Reflex Low-intensity sciatic nerve stimulation evoked 2 distinct peaks in sSNA at 88Ϯ5 ms and 175Ϯ3 ms (nϭ7; Figure  4AI ). Bilateral RVLM microinjection of SST (75 pmol per side) abolished the early peak but did not alter the late response (nϭ4; Figure 4AII ). In contrast, bilateral muscimol (0.5 nmol per side; nϭ4) into the same region abolished both early and late peaks and unmasked the short latency (34Ϯ1 ms) spinal component of the reflex ( Figure 4AIII ) that was also evident after C1 spinal cord transection (nϭ7; Figure  4AIV ).
Chemoreceptor Reflex
Anoxia evoked reproducible sympathoexcitatory (74Ϯ11%) and pressor responses (40Ϯ7 mm Hg; nϭ12; Figure 4B ). After bilateral SST (nϭ9) or lanreotide (nϭ3) injection into the RVLM, anoxia evoked much smaller sympathoexcitatory effects (42Ϯ7% and 29Ϯ5%; PϽ0.05) and no alteration in MAP (Ϫ2Ϯ2 and Ϫ2Ϯ9 mm Hg; PϽ0.001; Figure 4B ).
Baroreceptor Reflex
Tetanic ADN stimulation evoked baroreflex-mediated reductions of sSNA and MAP (Figures 2A, 2C , 3A, and 3C). After microinjection of SST or lanreotide, ADN stimulation continued to reduce sSNA to similar levels until baseline sSNA fell maximally, at which point ADN stimulation failed to alter sSNA.
Discussion
The major findings are that activation of sst2A receptors in the RVLM, located on only Ϸ35% of presympathetic neurons containing TH and/or PPE, evoked profound sympathetically mediated hypotension and bradycardia. Reflex function mediated by excitatory events in the RVLM was attenuated by SST injected into the RVLM. In contrast, muscimol inhibition of the RVLM abolished reflex function. These findings In the region containing TH (A1) and bulbospinal (CTB; A2) RVLM neurons, sst2A-ir (A3) is concentrated, whereas GAD67 in situ positive neurons are less common (A4). B shows the rectangle in A1. sst2A-ir (B3) colocalizes with CTB-ir (B2) and/or TH-ir (B1) RVLM neurons. Arrows indicate triple-labeled neurons; arrowhead indicates a CTB-ir, non-TH neuron that is sst2A-ir. C, Quadruple-labeled neurons with TH-ir (C1), CTB-ir (C2), sst2A-ir (C3), and VGluT2 in situ labeling (C4). D, Two sst2A-ir bulbospinal TH-ir neurons with 1 expressing PPE mRNA (D4, arrowhead) but not the other (arrow). E, A representative sst2A-ir, CTB-ir bulbospinal neuron; sst2A-ir is restricted to the plasma membrane of the soma and proximal dendrite. There is no obvious colocalization of sst2A-ir with synaptophysin (SYN)-ir terminals (E1), although the somata and dendrites of the sst2A-ir cells are closely apposed by SYN-ir terminals. Scale bar for A2, 200 m; B2 and C2, 100 m; D2, 50 m.
indicate that the activity of only a subpopulation of RVLM presympathetic neurons is altered by SST and shows for the first time that this cell population, or a part thereof, at least acutely, maintains sympathetic vasomotor tone, setting the baseline level of AP.
Here we showed that sst2A, 3, and 4 receptors were present on neurons within the RVLM, with sst2A receptors being the most highly abundant. This pattern of expression is consistent with previous investigations at other sites 20 -23 and extends recent work by Spary et al, 11 which colocalized sst2A with phenylethanolamine N-methyltransferase (PNMT) containing neurons in more caudal, ventral medulla. We used wellcharacterized sstR antibodies 23 of which the specificity has been validated by controls, including incubation of primary antibodies together with immunizing peptide 11, 24 and adsorption controls for Western and immunoblotting. 23, 25 Other control experiments included tissue incubation without primary antibodies 11 (present study). The sensitivity of the antibodies was appropriate, because distinct labeling for sst1 and sst2B was evident in the spinal cord, as reported previously, 20 and for sst4 within the nucleus ambiguus, despite little or no labeling within the RVLM. Consistent with studies of other brain sites, sst3 receptor expression was confined to neuronal cilia in the RVLM. 18, 23 sst2A receptors were found on approximately one third of bulbospinal RVLM neurons. Approximately half of the bulbospinal catecholamine containing VGlut2-positive neurons and one third of bulbospinal enkephalinergic neurons but not adjacent GABAergic neurons contained sst2A, consistent with a sympathetic premotor function. 11, 26 The sst2A receptor was present on the soma and dendrites of bulbospinal neurons but not on terminal boutons within the RVLM, indicating that into the RVLM of urethane-anesthetized and vagotomized rats substantially reduced HR, MAP, and sSNA but had little effect on PNA (A). After 2 hours of recovery, the spinal cord was transected (Spx) and the animal euthanized (KCl; A). Group data are shown in B. C, After RVLM identification using glutamate microinjection (Glu), SST was injected bilaterally into the RVLM, and 1 hour later lanreotide (Lan; 75 pmol per side) was injected into the same sites, evoking similar effects on sSNA, MAP, and HR. The peak sSNA effect of SST and Lan is comparable to the maximal sSNA inhibition achieved by baroreceptor loading with phenylephrine (PE;10 g/kg IV) and ADN stimulation. C, Group data of lanreotide is shown in B. The peak effects on MAP and sSNA of SST and Lan were similar, although the Lan response had a longer duration. Lan elicited a lesser effect on HR than SST. D, Dose-dependent responses in MAP, sSNA, and HR evoked by SST injected unilaterally and bilaterally and Lan injected bilaterally. The sympathoinhibition evoked by both drugs applied bilaterally is similar to that seen after spinal transection (Spx). *PϽ0.05, **PϽ0.01, ***PϽ0.001.
SST is involved in the postsynaptic modulation of select presympathetic output. Bilateral SST injection into the RVLM reversibly evoked sympathoinhibition, hypotension, and sympathetically mediated bradycardia to levels akin to those produced by cervical spinal transection. The doses used here were based on previous studies that administered SST in large volumes (0.5 to 1.5 L; 1.2 mmol/L) into the ventral 12, 13 or dorsal medulla or the cisterna magna (Ͼ10 L). 27 Although these studies noted mild hypotensive effects of SST administration, the striking respiratory effects (commonly apnea) were their main focus. Here we demonstrate that this SSTergic inhibition of central respiratory drive is evoked more caudally and is independent of the RVLM-mediated sympathoinhibitory effects. This suggests that SSTergic inputs control the respiratory and sympathetic outputs independently.
The effects of SST were mimicked by lanreotide, which has little effect at sst1 and 4 receptors but binds with high affinity to sst2, sst5, and, to a lesser extent, sst3 receptors. 7, 8 We and others have not detected significant expression of sst2B or sst5 in the medulla oblongata. 20, 22, 23, 28 Given the abundance of sst2A on RVLM presympathetic neurons and the abolition of SST-evoked cardiovascular responses by the sst2 receptor antagonist BIM-23627, it seems likely that the cardiovascular effects evoked by SST/lanreotide microinjection were mediated by sst2A. Because BIM-23627 had little effect when microinjected alone, it seems unlikely that SST is tonically released in the RVLM.
It is well established that neurons within the RVLM are essential for the tonic and reflex control of sympathetic activity. As seen previously 1,29,30 and described here, bilateral inhibition of the RVLM with muscimol reduces SNA and blood pressure to levels seen after cervical spinal cord transection and eliminates reflex sympathetic function. Substantial evidence indicates that normal function is retained after elimination of a large proportion of RVLM neurons. Inhibition of 50% of bulbospinal neurons, by unilateral muscimol microinjection, has little effect on sympathetic nerve activity or blood pressure, because any effects are rapidly compensated for by baroreceptor function. 31 Similarly, destruction of Ϸ84% of catecholaminergic bulbospinal neurons does not alter blood pressure (at least chronically), 30, 32 and subsequent inhibition of the RVLM, using muscimol, still causes blood pressure to drop to spinal levels, 30 indicating that some other cell population within the RVLM is the main locus of sympathetic tone generation. Because bilateral SST or lanreotide microinjection in the RVLM reduces the levels of sSNA and blood pressure to those seen after spinal cord transaction, we conclude that the vasomotor tone supporting AP is maintained and perhaps generated by bulbospinal RVLM neurons that express sst2A receptors.
Although bilateral injection of SST reduced sympathetic nerve activity to levels that could not be reduced further by baroreflex loading, sympathoexcitation evoked by somatosympathetic reflex or peripheral chemoreceptor activation was reduced to Ϸ40% to 50% of control levels. Sympathoexcitation evoked by chemoreceptor activation is significantly attenuated when catecholaminergic bulbospinal neurons are lesioned 33 but abolished when muscimol is injected into the RVLM. 29 Because sst2A receptors are found on a subpopulation of catecholamine-containing bulbospinal neurons, chemoreceptor reflex attenuation was unsurprising. Activation of the somatosympathetic reflex evokes a biphasic sympathetic response that is mediated by a glutamatergic synapse in the RVLM. 34 It is thought that the first peak is 
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attributable to activation of fast-conducting presympathetic neurons and the second peak mediated by more slowly conducting catecholaminergic neurons of the RVLM. [35] [36] [37] Bilateral muscimol in the RVLM acts on all of the presympathetic neurons, eliminating RVLM-mediated peaks, and unmasks the short-latency spinally mediated peak. In contrast, bilateral SST eliminated only the first RVLM peak, leaving the second largely untouched. This provides definitive functional evidence that SST inhibits a subpopulation of RVLM neurons that includes fast presympathetic presumably enkephalinergic neurons. These data indicate that SST acts on a subpopulation of Ϸ35% of RVLM presympathetic neurons containing the sst2A receptor and includes noncatecholaminergic and some catecholaminergic neurons, causing profound sympathoinhibition. This neuronal population, or part thereof, sets the level of resting AP.
Perspectives
The RVLM neurons critical for maintaining SNA and AP contain the sst2A receptor. Because elimination of most of the catecholamine-containing population has little effect on blood pressure, the enkephalinergic sst2A-positive, presumably fast-conducting subgroup, albeit small in number, is strongly implicated. We now hypothesize that they or a subpopulation of them may be crucial for generating sympathetic tone. Furthermore, sst2A receptor-expressing RVLM neurons contribute to the elaboration of sympathoexcitatory chemoreceptor and somatosympathetic reflexes. The source and conditions under which SST is released in the RVLM are as yet unknown and demand investigation. Sympathetic activity is increased in hypertension 3, 38 and heart failure, and the activity of RVLM neurons is raised, at least in animal models of hypertension 39 (see, however 40 ). Future therapies that target SST transmission or sstR expression in the medulla may prove effective treatment for these diseases. . AI, SN stimulation consistently evoked 2 distinct peaks in sSNA of similar latencies and intensities. AII, Bilateral RVLM injection of SST abolished the early supraspinal peak but had no effect on the late supraspinal peak. AIII, Bilateral RVLM injection of muscimol abolished both peaks, unmasking a very early peak that occurs at the same latency as the spinally mediated reflex (shaded line). AIV, C1 spinal transection eliminated both supraspinal peaks, and the spinal peak is evident presumably because of removal of descending inhibition. B demonstrates that acute anoxia (12 seconds) evoked reproducible pressor and sympathoexcitatory effects that were attenuated by bilateral SST. Grouped data show that bilateral SST or Lan abolished the pressor response and attenuated the sympathetic response to anoxia. 
Preparation of digoxigenin (DIG) labeled riboprobes
To prepare riboprobes for preproenkephalin (PPE), glutamic acid decarboxylase (GAD67), vesicular glutamate transporter 2 (VGluT2) and preprosomatostatin (PPS), a DNA fragment of each gene was first amplified by PCR from rat brain cDNA using forward and reverse primers with SP6 and T7 promoters attached at the 5′ end, respectively (Table S1 ). The sense and antisense riboprobes were then transcribed in vitro using DIG-11-UTP (Roche Applied Sciences, Germany) and T7 or Sp6 RiboMAX large scale RNA production system (Promega, Madison, USA).
Combined in situ hybridization and immunohistochemistry A combined method for in situ hybridization and immunohistochemistry was used to reveal neurons that contain mRNAs for GAD67, VGluT2, PPE or PPS and immunoreactivity (ir) for tyrosine hydroxylase (TH), somatostatin receptor 2A (sst2A) and CTB as described Jackson ImmunoResearch, West Grove, USA).
Diaminobenzidine (DAB)-based immunocytochemistry
The CTB injection site in spinal cord and the distribution of immunoreactivity for sst1, sst2A, sst2B, sst3 and sst4 (Gramsch Laboratories, Germany) in the ventrolateral medulla (VLM)
were revealed by a nickel-intensified DAB reaction 2 . The concentrations of Gramsch sstR antibodies used were similar to those used in previous studies [3] [4] [5] [6] . Sections were pretreated with 50% ethanol for 30 minutes, followed by 3 washes with TPBS. Spinal sections were incubated with sheep anti-CTB (1:50,000) and VLM sections were incubated with, rabbit anti-sst1 (1:1000), guinea pig anti-sst2A (1:8000), rabbit anti-sst2B (1:500), rabbit anti-sst3
(1:2000) or rabbit anti-sst4 (1:4000) for 48 hours at room temperature. Sections were washed with TPBS and incubated in biotinylated donkey anti-sheep/rabbit/guinea pig (1:500, Jackson
ImmunoResearch, West Grove, USA) overnight. Following TPBS washes as above, sections
were incubated with ExtrAvidin-HRP (1:1000, Sigma-Aldrich, Australia) for 4 hours.
Imaging and quantitation
Sections were mounted sequentially on glass slides and coverslipped with ProLong Antifade (Molecular Probes, Invitrogen, Australia) and were viewed with a microscope (Leica, or Zeiss imager Z.1, Germany). TH, sst2A and CTB positive neurons were visualized under dark-field with appropriate filter sets to discriminate different fluorescent tags while in situ positive neurons were visualized using bright-field illumination. Neurons were considered to be double-or triple-labeled only when the images completely overlapped and were in the same focal plane. Images were acquired and processed using a Spot 2 digital camera and software (Diagnostic Instruments, Australia).
The RVLM region examined contained the rostral C1 adrenergic and extends from 11.8 to 12.4 mm caudal to Bregma. The RVLM was defined as the area ventral to the nucleus ambiguus, medial to the spinal trigeminal tract and lateral to the dorsal nucleus of the inferior olive. Labeled RVLM neurons were counted from 4 hemi-sections each separated by 200 μm.
Electrophysiological experiments
Anesthesia was induced with halothane (3.5 % in 100 % O 2 ) followed by injection of urethane (ethyl carbamate, 10 % w/v in saline, 1.3 g/kg, i.p.). Supplemental doses of urethane (0.2 mL i.v.) were administered as required to eliminate blood pressure responses to nociceptive stimuli. Body temperature was maintained between 36 °C and 37.5 °C using a homeothermic heating blanket (Harvard Apparatus, Holliston, MA).
Surgery and electrophysiological recordings
The trachea was cannulated to permit artificial ventilation. The right jugular vein and carotid artery were cannulated to permit drug administration and record AP, respectively. Heart rate (HR) was derived from AP. The left greater splanchnic preganglionic and phrenic nerves were isolated, tied with 6/0 silk thread, cut, and recorded using bipolar silver hook electrodes.
Neurograms were amplified (x10,000, CWE Inc., USA), band pass filtered (50-1000 Hz), sampled at 2 kHz (1401plus, CED Ltd., UK), and recorded on computer using Spike2 software (CED Ltd. Cambridge, UK). In 10 animals, the left aortic depressor nerve (ADN) was isolated, cut, and mounted on bipolar silver hook electrodes. Short trains of stimuli were applied to the ADN (50 pulse train, 100 Hz, 0.2 ms pulse width, 3 -5x threshold). In 7 animals, the left sciatic nerve (SN) was isolated, cut and the proximal end prepared for stimulation. Waveform averages of somatosympathetic responses evoked by low intensity (2x threshold; ~0.5 V), single pulse (0.2 ms) stimuli were generated from 50 consecutive sweeps at 2-second intervals. Data were rectified but not smoothed for the generation of waveform averages.
Animals were placed in a stereotaxic frame and the dorsal medullary surface was exposed by occipital craniotomy. Rats were vagotomized and paralyzed with pancuronium bromide (0. was dissolved in 5% dimethylsulphoxide (DMSO)/PBS. Transient small pressor responses (Fig 2C) evoked immediately following injection were attributed to the sympathoexcitation evoked by the vehicle DMSO in the RVLM as described previously 8 .
The RVLM was mapped to identify sites at which glutamate microinjection evoked short latency pressor (>40 mmHg) and sympathoexcitatory (50% increase from baseline activity)
responses. Drugs were then injected at the same sites. Bilateral injections, when required, were made within one minute of each other.
In 8 experiments, the spinal cord was transected at C1 prior to euthanasia. The ADN was stimulated every 5 minutes throughout the experiment in 10 animals. Isocapnic anoxia was evoked by ventilating with nitrogen for 12 seconds (s) in 10 animals.
Sites of drug injection were marked by pontamine sky blue or colloidal gold injection, the rat was killed (3 mol/L, 0.5 mL KCl, i.v.) and the brainstem removed and placed in fixative (4% Table S1 . Primers used for PCR-generated riboprobes 
